Suppressing a protein builds muscle mass, improves markers of heart health without weight loss
Suppressing production of the protein myostatin enhances muscle mass and leads to significant improvements in markers of heart and kidney health, according to a study conducted in mice. Joshua T. Butcher, PhD, a postdoctoral fellow at the Vascular Biology Center at Augusta University, will present the work at the American Physiological Society’s annual meeting during the Experimental Biology 2017 meeting, to be held April 22–26 in Chicago.
The researchers zeroed in on myostatin because it is known as a powerful inhibitor of skeletal muscle growth, meaning that people with more myostatin have less muscle mass and people with less myostatin have more muscle mass. Studies suggest obese people produce more myostatin, which makes it harder to exercise and harder to build muscle mass.
“Given that exercise is one of the most effective interventions for obesity, this creates a cycle by which a person becomes trapped in obesity,” Butcher said.
Obesity is linked with a range of factors that increase the risk of heart disease and diabetes, including high blood pressure, high cholesterol, insulin resistance and kidney damage. The researchers bred four groups of mice: lean and obese mice with uninhibited myostatin production and lean and obese mice that were unable to produce myostatin. As expected, mice that were unable to produce myostatin developed markedly higher muscle mass, though the obese mice remained obese even with more muscle. The obese mice that were unable to produce myostatin showed markers of cardiovascular and metabolic health that were on par with their lean counterparts and dramatically better than obese mice with uninhibited myostatin production.
“In our muscular obese mouse, despite full presentation of obesity, it appears that several of these key pathologies are prevented,” Butcher said. “While much more research is needed, at this point myostatin appears to be a very promising pathway for protection against obesity-derived cardiometabolic dysfunction.
“Ultimately, the goal of our research would be to create a pill that mimics the effect of exercise and protects against obesity. A pill that inhibits myostatin could also have applications for muscle wasting diseases, such as cancer, muscle dystrophy and AIDS,” he added.
Learn more: One Step Closer to an “Exercise Pill”
The Latest on: Exercise pill
- 7 Things No One Tells You Happens When You Come Off The Pill on April 18, 2019 at 1:00 am
For example, stress, excessive exercise and hormonal conditions like Polycystic Ovarian Syndrome." 6. Your PMS symptoms might be extra strong in the first three months If you used to find yourself ... […]
- University of Minnesota tests ‘smart’ pills for cancer patients on April 16, 2019 at 6:55 pm
“Impossible (to solve) if you don’t.” In addition to receiving information from the digital pills, the patches can monitor patients’ heart rates, exercise patterns and sleep levels. Greeno said he was ... […]
- The FDA Just Approved a New Prescription Weight Management Pill on April 16, 2019 at 2:05 pm
(Related: How to Rekindle Exercise and Weight-Loss Motivation When You Just Want ... twice a day with water—once 20 minutes before lunch and again before dinner. The pill contains a hydrogel matrix ... […]
- 5 Questions We Have About the New FDA-Approved Weight Loss Pill on April 16, 2019 at 1:24 pm
Cellulose (what the pill is made of) is a non-digestible plant fiber ... While PLENITY says it is meant to be used in combination with a healthy diet and exercise, I wonder if it will actually help ... […]
- Can a Pill Really Help You Live Longer? on April 16, 2019 at 11:31 am
Exercise is important for preventing the loss ... Bioavailability is the idea of getting something from the pill or capsule to the places in the body where it’s most needed. […]
via Google News and Bing News